AILBRY - Article Search
Serach over 250 million academic articles from all areas of study
Results for 'Avelumab'
:
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Publication Year: 2019
DOI: https://doi.org/10.1056/nejmoa1816047
Abstract:
Add to Library
Authors:
Robert J. Motzer
Konstantin Penkov
John B.A.G. Haanen
Brian I. Rini
Laurence Albigès
Matthew T. Campbell
Balaji Venugopal
Christian Kollmannsberger
Sylvie Négrier
Motohide Uemura
Jae L. Lee
Aleksandr Vasiliev
Wilson H. Miller
Howard Gurney
Manuela Schmidinger
James Larkin
Michael B. Atkins
Jens Bedke
B. Yа. Alekseev
Jing Wang
Mariangela Mariani
Paul B. Robbins
Aleksander Chudnovsky
Camilla Fowst
Hariharan Subramanian
Bo Huang
Alessandra di Pietro
Toni K. Choueiri
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
Publication Year: 2020
DOI: https://doi.org/10.1056/nejmoa2002788
Abstract:
Add to Library
Authors:
Thomas Powles
Se Hoon Park
Éric Voog
Claudia Caserta
Begoña P. Valderrama
Howard Gurney
Haralabos P. Kalofonos
Siniša Radulović
Wim Demey
Anders Ullén
Yohann Loriot
Srikala S. Sridhar
Norihiko Tsuchiya
Evgeny Kopyltsov
Cora N. Sternberg
Joaquim Bellmunt
Jeanny B. Aragon‐Ching
Daniel P. Petrylak
Robert J Laliberte
Jing Wang
Bo Huang
Craig B. Davis
Camilla Fowst
Nuno Costa
John A. Blake-Haskins
Alessandra di Pietro
Petros Grivas
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
Publication Year: 2016
DOI: https://doi.org/10.1016/s1470-2045(16)30364-3
Abstract:
Add to Library
Authors:
Howard L. Kaufman
Jeffery S. Russell
Omid Hamid
Shailender Bhatia
Patrick Terheyden
Sandra P. D’Angelo
Kent C. Shih
Célèste Lebbé
Gerald P. Linette
Michèle Milella
Isaac Brownell
Karl D. Lewis
Jochen H. Lorch
Kevin M. Chin
Lisa Mahnke
Anja von Heydebreck
Jean-Marie Cuillerot
Paul Nghiem
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
Publication Year: 2017
DOI: https://doi.org/10.1007/s10549-017-4537-5
Abstract:
Add to Library
Authors:
Luc Dirix
István Takács
Guy Jérusalem
Petros Nikolinakos
Hendrik‐Tobias Arkenau
Andres Forero‐Torres
Ralph V. Boccia
Marc E. Lippman
Robert A. Somer
Martin Šmakal
Leisha A. Emens
Borys Hrinczenko
W. Jeff Edenfield
Jayne S. Gurtler
Anja von Heydebreck
H. Grote
Kevin M. Chin
Erika Hamilton
Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti–PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells
Publication Year: 2015
DOI: https://doi.org/10.1158/2326-6066.cir-15-0059
Abstract:
Add to Library
Authors:
Benjamin Boyerinas
Caroline Jochéms
Massimo Fantini
Christopher R. Heery
James L. Gulley
Kwong Y. Tsang
Jeffrey Schlom
Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study
Publication Year: 2017
DOI: https://doi.org/10.1200/jco.2016.71.6795
Abstract:
Add to Library
Authors:
Andrea B. Apolo
Jeffrey R. Infante
Ani Sarkis Balmanoukian
Manish R. Patel
Ding Wang
Karen Kelly
Anthony Mega
Carolyn D. Britten
Alain Ravaud
Alain C. Mita
Howard Safran
Thomas E. Stinchcombe
Marko Srdanov
Arnold B. Gelb
Michael Schlichting
Kevin M. Chin
James L. Gulley
Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer
Publication Year: 2019
DOI: https://doi.org/10.1001/jamaoncol.2018.6258
Abstract:
Add to Library
Authors:
Mary L. Disis
Matthew H. Taylor
Karen Kelly
J. Thaddeus Beck
Michael S. Gordon
Kathleen N. Moore
Manish R. Patel
Jorge Chaves
Haeseong Park
Alain C. Mita
Erika Hamilton
Christina M. Annunziata
H. Grote
Anja von Heydebreck
Jaspreet Singh Grewal
Vikram K. Chand
James L. Gulley
Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma
Publication Year: 2018
DOI: https://doi.org/10.1001/jamaoncol.2018.0077
Abstract:
Add to Library
Authors:
Sandra P. D’Angelo
Jeffery S. Russell
Célèste Lebbé
Bartosz Chmielowski
Thilo Gambichler
Jean‐Jacques Grob
Felix Kiecker
Guilherme Rabinowits
Patrick Terheyden
Isabella Zwiener
Marcis Bajars
Meliessa Hennessy
Howard L. Kaufman
Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
Publication Year: 2018
DOI: https://doi.org/10.1093/annonc/mdy264
Abstract:
Add to Library
Authors:
Yu Jeong Bang
Eduardo Yañez Ruiz
Eric Van Cutsem
Kuhn‐Uk Lee
Lucjan Wyrwicz
Michael Schenker
María Alsina
Min‐Hee Ryu
Hyun Cheol Chung
Ludovic Evesque
Salah-Eddin Al-Batran
Se Hoon Park
M. Lichinitser
Narikazu Boku
Markus Moehler
Janet Hong
Hua Xiong
Roland Hallwachs
Ilaria Conti
Julien Taı̈eb
Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
Publication Year: 2020
DOI: https://doi.org/10.1016/j.annonc.2020.04.010
Abstract:
Add to Library
Authors:
Toni K. Choueiri
Robert J. Motzer
Brian I. Rini
John B.A.G. Haanen
Matthew T. Campbell
B. Venugopal
Christian Kollmannsberger
Gwénaëlle Gravis
Mamoru Uemura
J.L. Lee
Marc‐Oliver Grimm
Howard Gurney
Manuela Schmidinger
James Larkin
Michael B. Atkins
Sumanta K. Pal
J. Wang
Mariangela Mariani
S. Krishnaswami
Paul Cislo
A. Chudnovsky
Camilla Fowst
Bo Huang
Alessandra di Pietro
Laurence Albigès
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial
Publication Year: 2017
DOI: https://doi.org/10.1016/s1470-2045(17)30900-2
Abstract:
Add to Library
Authors:
Manish R. Patel
John Ellerton
Jeffrey R. Infante
Manish Agrawal
Michael S. Gordon
Raid Aljumaily
Carolyn D. Britten
Luc Dirix
Keun‐Wook Lee
Mathew Taylor
Patrick Schöffski
Ding Wang
Alain Ravaud
Arnold B. Gelb
Junyuan Xiong
Galit Rosen
James L. Gulley
Andrea B. Apolo
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial
Publication Year: 2018
DOI: https://doi.org/10.1186/s40425-017-0310-x
Abstract:
Add to Library
Authors:
Howard L. Kaufman
Jeffery S. Russell
Omid Hamid
Shailender Bhatia
Patrick Terheyden
Sandra P. D’Angelo
Kent C. Shih
Célèste Lebbé
Michèle Milella
Isaac Brownell
Karl D. Lewis
Jochen H. Lorch
Anja von Heydebreck
Meliessa Hennessy
Paul Nghiem
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer
Publication Year: 2017
DOI: https://doi.org/10.1093/jnci/djx213
Abstract:
Add to Library
Authors:
Anshuman Panda
Janice M. Mehnert
Kim M. Hirshfield
Gregory Riedlinger
Sherri Damare
Tracie Saunders
Michael P. Kane
Levi Sokol
Mark N. Stein
Elizabeth Poplin
Lorna Rodríguez-Rodríguez
Ann W. Silk
Joseph Aisner
Nancy Chan
Jyoti Malhotra
Melissa Frankel
Howard L. Kaufman
Siraj M. Ali
Jeffrey S. Ross
Eileen White
Gyan Bhanot
Shridar Ganesan
Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma
Publication Year: 2019
DOI: https://doi.org/10.1001/jamaoncol.2018.5428
Abstract:
Add to Library
Authors:
Raffit Hassan
Anish Thomas
John Nemunaitis
Manish R. Patel
Jaafar Bennouna
Franklin L. Chen
Jean‐Pierre Delord
Afshin Dowlati
Samith T. Kochuparambil
Matthew H. Taylor
John D. Powderly
Ulka N. Vaishampayan
Claire F. Verschraegen
H. Grote
Anja von Heydebreck
Kevin M. Chin
James L. Gulley
Avelumab: First Global Approval
Publication Year: 2017
DOI: https://doi.org/10.1007/s40265-017-0749-6
Abstract:
Add to Library
Authors:
Found 10981 results in 0.065 seconds
What is Boolean Searches
Including any of the words AND
, OR
, or NOT
in any of your searches will enable
boolean search. Those words must be UPPERCASE . You can use this in all searches, including using
the search parameter, and using search filters.
This allows you to craft complex queries using those boolean operators along with parentheses and quotation marks.
Surrounding a phrase with quotation marks will search for an exact match of that phrase, after stemming and
stop-word removal (be sure to use double quotation marks — "
). Using parentheses will specify order of
operations for the boolean operators. Words that are not separated by one of the boolean operators will be
interpreted as AND
.
Behind the scenes, the boolean search is using Elasticsearch's query string query on the searchable fields (such as
title, abstract, and fulltext for works; see each individual entity page for specifics about that entity). Wildcard
and fuzzy searches using *
, ?
or ~
are not allowed; these characters will be
removed from any searches. These searches, even when using quotation marks, will go through the same cleaning as
described above, including stemming and removal of stop words.
Example Search
Search for works that mention "elmo"
and "sesame street"
, but not the words
"cookie"
or "monster"
:
"elmo" AND "sesame street" NOT "cookie" NOT "monster"